Zobrazeno 1 - 4
of 4
pro vyhledávání: '"L. Leite Barros"'
Autor:
L. Leite Barros, A. O. M. C. Damião, Eduardo Luiz Rachid Cançado, R S F Junior, Jane Oba, Claudio L. Hashimoto, Aytan Miranda Sipahi, J C Silva, Alexandre Carlos, Matheus Azevedo, M F Carvalho
Publikováno v:
Journal of Crohn's and Colitis. 15:S283-S284
Background Ulcerative colitis (UC) is a chronic inflammatory disease characterized by relapsing and remitting course of bloody diarrhea. UC patients are at higher risk of dysplasia and colorectal cancer (CRC) when compared to the general population,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4333cdf0d72d27ed8f716d54943a9ef7
https://doi.org/10.1093/ecco-jcc/jjab076.363
https://doi.org/10.1093/ecco-jcc/jjab076.363
Autor:
Natália Sousa Freitas Queiroz, Jane Oba, L. Leite Barros, Karoline Soares Garcia, Luciane Milani, Alexandre Carlos, A. O. M. C. Damião, Aytan Miranda Sipahi, Matheus Azevedo, F F Justus, Camila Cunha Gonzaga Lima
Publikováno v:
Journal of Crohn's and Colitis. 15:S445-S445
Background Patients with inflammatory bowel diseases (IBD) have a greater risk of developing opportunistic infections, especially if they are under immunosuppressants and biological agents. Anti-tumor necrosis factor alpha (anti-TNF) has considerably
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8488a40896a9dae913f0c13ecdd0968
https://doi.org/10.1093/ecco-jcc/jjab076.572
https://doi.org/10.1093/ecco-jcc/jjab076.572
Autor:
Natália Sousa Freitas Queiroz, Jane Oba, Ana Elisa Rabe Caon, Matheus Azevedo, Eduardo Luiz Rachid Cançado, Myrla Lorenna Andrade Cruz, Aytan Miranda Sipahi, L. Leite Barros, M Braga, Aderson Omar Mourão Cintra Damião, Alexandre Carlos, L Milane, Camilla de Almeida Martins
Publikováno v:
Journal of Crohn's and Colitis. 14:S258-S258
Background Primary sclerosing cholangitis (PSC) is a chronic and progressive cholestatic disease associated with inflammatory bowel diseases (IBD) in 70% of cases.1 When combined, they present as one distinct phenotypical disease referred to as PSC-I
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59738479760177ebe73308d8106cd6f2
https://doi.org/10.1093/ecco-jcc/jjz203.360
https://doi.org/10.1093/ecco-jcc/jjz203.360
Autor:
Saul D; Division of Endocrinology, Mayo Clinic, Rochester, MN 55905, USA.; Robert and Arlene Kogod Center on Aging, Mayo Clinic, Rochester, MN 55905, USA.; Department of Trauma, Orthopedics and Reconstructive Surgery, Georg-August-University of Göttingen, 37075 Göttingen, Germany., Leite Barros L; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.; Department of Gastroenterology, School of Medicine, University of São Paulo, São Paulo 05403-000, Brazil., Wixom AQ; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA., Gellhaus B; Department of Trauma, Orthopedics and Reconstructive Surgery, Georg-August-University of Göttingen, 37075 Göttingen, Germany., Gibbons HR; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA., Faubion WA; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA., Kosinsky RL; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN 55905, USA.
Publikováno v:
International journal of molecular sciences [Int J Mol Sci] 2022 Mar 12; Vol. 23 (6). Date of Electronic Publication: 2022 Mar 12.